Resminostat maintenance for advanced cutaneous lymphoma: RESMAIN study
Maintenance therapy options for cutaneous T-cell lymphomas could be improved. Here, Rudolf Stadler, MD, PhD, of the University Medical Center Minden, Minden, Germany, discusses the RESMAIN study (NCT0...
Author: VJHemOnc
Added: 10/02/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Cutaneous T cell lymphoma | Germany Health | Lymphoma | Study | T-cell Lymphoma